Insider Trading: Repros Therapeutics Inc (RPRX.W)
RPRX.W on CBOE When Trading NASDAQ Global Select Market
16.50USD
24 May 2013
16.50USD
24 May 2013
Price Change (% chg)
$0.72 (+4.56%)
$0.72 (+4.56%)
Prev Close
$15.78
$15.78
Open
$15.85
$15.85
Day's High
$16.81
$16.81
Day's Low
$15.85
$15.85
Volume
1,500
1,500
Avg. Vol
4,248
4,248
52-wk High
$20.18
$20.18
52-wk Low
$7.78
$7.78
| PERCEPTIVE ADVISORS L L C | Options Exercised: 0 | ||
| Trade Date: | Sunday, 7 Aug 2011 | Price: | 7.50 |
| Title: | Beneficial Owner of More than 10% Class | Shares Held: | 1,581,660 |
| Type Traded: | Indirect | Net Change in Shares This Filing: | 23,600 |
Institutional Holders
| % Shares Owned: | 0.00% |
| # of Holders: | 96 |
| Total Shares Held: | 18,818,676 |
| 3 Mo. Net Change: | 5,705,074 |
| # New Positions: | 24 |
| # Closed Positions: | 13 |
| # Increased Positions: | 54 |
| # Reduced Positions: | 35 |
| # Net Buyers: | 19 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
Nola Masterson |
65 | 2009 | Independent Chairman of the Board |
Joseph Podolski |
64 | 2009 | President, Chief Executive Officer, Director |
Katherine Anderson |
54 | 2011 | Chief Financial Officer, Chief Accounting Officer, Secretary |
Jaye Thompson |
47 | 2013 | Senior Vice President - Clinical and Regulatory |
Ronald Wiehle |
63 | Vice President - Research & Development | |
Saira Ramasastry |
2013 | Director | |
Daniel Cain |
66 | 2008 | Independent Director |
Michael Wyllie |
61 | 2011 | Independent Director |

